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associated with Asperger Syndrome
Agnese Di Napoli1*, Varun Warrier1, Simon Baron-Cohen1,2* and Bhismadev Chakrabarti3Abstract
Background: Autism Spectrum Conditions (ASC) are neurodevelopmental conditions characterized by difficulties in
communication and social interaction, alongside unusually repetitive behaviours and narrow interests. Asperger
Syndrome (AS) is one subgroup of ASC and differs from classic autism in that in AS there is no language or general
cognitive delay. Genetic, epigenetic and environmental factors are implicated in ASC and genes involved in neural
connectivity and neurodevelopment are good candidates for studying the susceptibility to ASC. The aryl-hydrocarbon
receptor nuclear translocator 2 (ARNT2) gene encodes a transcription factor involved in neurodevelopmental processes,
neuronal connectivity and cellular responses to hypoxia. A mutation in this gene has been identified in individuals with
ASC and single nucleotide polymorphisms (SNPs) have been nominally associated with AS and autistic traits in previous
studies.
Methods: In this study, we tested 34 SNPs in ARNT2 for association with AS in 118 cases and 412 controls of Caucasian
origin. P values were adjusted for multiple comparisons, and linkage disequilibrium (LD) among the SNPs analysed was
calculated in our sample. Finally, SNP annotation allowed functional and structural analyses of the genetic variants in
ARNT2. We tested the replicability of our result using the genome-wide association studies (GWAS) database of
the Psychiatric Genomics Consortium (PGC).
Results: We report statistically significant association of rs17225178 with AS. This SNP modifies transcription
factor binding sites and regions that regulate the chromatin state in neural cell lines. It is also included in a LD
block in our sample, alongside other genetic variants that alter chromatin regulatory regions in neural cells.
Conclusions: These findings demonstrate that rs17225178 in the ARNT2 gene is associated with AS and support
previous studies that pointed out an involvement of this gene in the predisposition to ASC.
Keywords: Autism spectrum conditions (ASC), Asperger Syndrome (AS), Aryl-hydrocarbon receptor nuclear
translocator 2 (ARNT2), Single nucleotide polymorphisms (SNPs)Background
Autism Spectrum Conditions (ASC) are a group of neurode-
velopmental conditions defined by difficulties in communi-
cation and social interaction, alongside unusually repetitive
behaviours and narrow interests. Asperger Syndrome (AS) is
a subtype of these conditions, where there is no delay in lan-
guage or cognitive development [1]. The incidence of ASC
in the general population is approximately 1 in 100 [2].
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unless otherwise stated.individuals with AS [3] and classic autism [4], respectively,
although the true sex ratio in AS may be closer to the
sex ratio in classic autism because of under-detection
of AS in females [5]. ASC are heritable [6,7] and multi-
factorial conditions, where genetic, epigenetic and en-
vironmental factors are involved [8,9].
ASC are neurodevelopmental in origin, and accordingly,
genes involved in neural development and connectivity
are good candidate genes for studying the genetics of
these conditions [10,11]. The aryl-hydrocarbon receptor
nuclear translocator 2 (ARNT2) gene encodes a tran-
scription factor of the basic helix-loop-helix (bHLH)-
Per-ARNT-Sim (PAS) family, which is mainly expressed
in the kidney and central nervous system [12,13]. ARNT2ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and regulates cellular responses to hypoxia [14]. It also di-
merizes with single-minded homolog 1 (SIM1) and partici-
pates in the development of paraventricular and supraoptic
nuclei in mice [15]. Variants in the SIM1 gene have been
associated with obesity in humans and have been shown to
reduce transcriptional activity of SIM1 combined with
ARNT2. Interestingly, 11 individuals carrying these vari-
ants have reported atypical behaviours, such as ASC [16].
SIM1 controls the expression of methyl CpG binding pro-
tein 2 (MECP2) gene, which is disrupted in individuals
with Rett Syndrome who display autistic features [17].
Mecp2 mouse models show typical features of Rett Syn-
drome [18,19], and knockout mice with a deletion of
Mecp2 in Sim1-expressing neurons display altered social
behaviour [20]. Heterozygous Arnt2 mutant mice lack
secretory neurons in paraventricular and supraoptic
nuclei, implicating the involvement of ARNT2 in neu-
rodevelopmental processes [21]. Arnt2 and Sim1 are
also involved in long-range axonal guidance and hence
lay down the connections between the hypothalamus
and the spinal cord in zebrafish [22]. ARNT2 is a tran-
scription factor in mouse hippocampus [23] and regu-
lates the brain-derived neurotrophic factor (Bdnf ) gene
that controls neural activity and is related to several
human neurodevelopmental conditions [24]. A recent
study by Lin and colleagues proposed a role of ARNT2
in the predisposition to ASC. They tested the levels of
expression of candidate genes for ASC in neural aggre-
gates in human stem cell models (comparable to a tel-
encephalon in the early stages of development) after
heat shock and they observed an alteration of ARNT2
expression [25]. One study reported a missense muta-
tion in ARNT2 in individuals with ASC [26] and a pre-
vious study from our laboratory identified nominal
associations between single nucleotide polymorphisms
(SNPs) rs3901896 and rs4778599 with AS and autistic
traits, respectively [27]. A recent study has reported
nominally significant association for SNPs in ARNT2
and SIM1 with autistic traits in a general population
sample [28].
In the current study, we tested 34 SNPs in ARNT2 for
association with AS in an independent sample, com-
posed of 118 cases and 412 controls. We found a signifi-
cant association of rs17225178 with AS after correcting
for multiple comparisons and a nominal association of
rs3848173 with AS. To test the replicability of this ob-
servation, we analysed genome-wide association studies
(GWAS) data from the Psychiatric Genomics Consor-
tium (PGC), which tested SNPs for association with
ASC in case–control and family-based samples [29]. Our
study provides further support for a role of ARNT2 in
ASC and in particular it points out an involvement of a
SNP (that is rs17225178) in the predisposition to AS.Methods
Participants
Participants were recruited by advertisement from the
volunteer database of the Autism Research Centre in
Cambridge (United Kingdom). They included both indi-
viduals with an AS diagnosis and individuals who were
not diagnosed with AS and did not have any close family
member with a diagnosis of ASC. All individuals com-
pleted the Autism Spectrum Quotient (AQ) online [30]
to separate cases and controls from the two extreme
ends of the AQ continuum. Eighty percent of individuals
with an ASC diagnosis score above 32 on the AQ [31].
Cases were previously diagnosed by independent clini-
cians in the United Kingdom for having AS using the
International Statistical Classification of Diseases and
Related Health Problems, Tenth Revision (ICD-10) [32]
or the Diagnostic and Statistical Manual of Mental Dis-
orders, Fourth Edition, Text Revision (DSM-IV-TR) [1]
criteria, at recognized clinics in the United Kingdom, by
trained psychiatrists or clinical psychologists. A propor-
tion of these were diagnosed at our clinic in Cambridge
(the CLASS Clinic). Individuals without an ASC diagno-
sis and with an AQ score below or equal to 24 were se-
lected as controls. This ensured that individuals with
high autistic traits but without a diagnosis of ASC (the
so-called “Broader Autism Phenotype” (BAP) [33]) were
not included in the study, as this can confound the ana-
lysis. The AQ measures autistic traits, has high heritabil-
ity [34] and has a normal distribution in the general
population [30]. Individuals in the general population
show a mean AQ score of 16.4 ± 6.3, while individuals
with AS have a mean AQ score of 35.8 ± 6.5 [31]. All par-
ticipants resided in the United Kingdom when the study
was conducted and reported Caucasian ancestry for at
least three generations. Overall, we tested 530 individuals,
among them 118 cases (74 males and 44 females) with a
mean AQ score of 35.6 ± 8.9 (males mean: 35.1 ± 8.7,
females mean: 36.6 ± 8.8) and 412 controls (185 males
and 227 females) with a mean AQ score of 14.9 ± 5.0
(males mean: 16.0 ± 4.4, females mean: 13.9 ± 5.1) (Table 1).
SNP selection and genotyping
Thirty-four SNPs in the ARNT2 gene were selected from
80704652 bp to 80889940 bp on chromosome 15 with a
mean inter-SNP distance of 7 Kb (GRCH37.p10 Primary
Assembly, National Center for Biotechnology Informa-
tion [NCBI]). We did not have a specific hypothesis
about any SNP in particular and tested multiple SNPs
within the same gene to identify a possible association of
the gene with a given phenotype [35]. All chosen SNPs
had a minor allele frequency (MAF) > 0.05 in the Hap-
Map CEU (Utah residents with northern and western
European ancestry) population (HapMap genome browser,
release 27) and were available in the TaqMan SNP
Table 1 Schematic description of the participants enrolled in the current study
Status of the
participants
Total number Number of males Number of females Total AQ score AQ score in males AQ score in females
Cases 118 74 44 35.6 ± 8.9 35.1 ± 8.7 36.6 ± 8.8
Controls 412 185 227 14.9 ± 5.0 16.0 ± 4.4 13.9 ± 5.1
Total numbers of participants and total AQ scores for cases and controls are reported. These values stratified by sex are also reported. AQ, Autism Spectrum
Quotient.
Table 2 SNPs in ARNT2 analysed in the current study
SNP ID Chromosomal
position
Major/minor allele MAF (CEU)
rs1446336 80704652 T/A 0.407
rs16972073 80709303 G/C 0.075
rs12594558 80709766 C/T 0.259
rs1026016 80710955 C/T 0.153
rs3910982 80712122 C/A 0.333
rs1020397 80718738 G/C 0.283
rs4778790 80721271 A/G 0.389
rs1912 80723361 C/T 0.138
rs8034535 80725974 A/G 0.208
rs8036233 80729687 T/A 0.474
rs3901896 80734097 C/T 0.394
rs3848173 80734588 C/T 0.129
rs17788120 80742881 T/C 0.411
rs17225178 80743866 T/A 0.081
rs3848175 80747103 G/A 0.281
rs895444 80749761 A/G 0.111
rs12591546 80754740 G/T 0.275
rs4778795 80760069 G/T 0.226
rs12905523 80760688 T/C 0.240
rs4778798 80770223 T/C 0.042
rs7181179 80778586 T/C 0.009
rs4778599 80781763 G/A 0.296
rs7175825 80795419 G/C 0.442
rs11858186 80801472 C/T 0.491
rs12439920 80804741 G/A 0.103
rs11072922 80806183 C/T 0.159
rs4778604 80837819 C/T 0.492
rs4423382 80854992 A/C 0.155
rs10851935 80859935 T/C 0.341
rs7403706 80861365 T/C 0.168
rs7403013 80874261 G/A 0.127
rs4072568 80884025 G/A 0.137
rs6495511 80888783 A/G 0.243
rs1139650 80889940 A/G 0.093
The table shows SNP ID and chromosomal position of genetic variants
analysed in this study. Major/minor allele and MAF values in the CEU
population for each SNP are also reported. CEU, Utah residents with northern
and western European ancestry; MAF, minor allele frequency; SNP, single
nucleotide polymorphism.
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City, CA, USA), that was used for genotyping in the
current study. rs1446336, rs8034535 and rs7175825
are tag SNPs, as indicated by the HapMap genome
browser (release 27). The most upstream SNP is rs1446336
(Chr 15: 80704652) and the most downstream is rs1139650
(Chr 15: 80889940) (see Table 2). Buccal samples were
collected by mail from the participants and DNA was
extracted and anonymized [36]. SNP genotyping was
performed following the protocol previously reported
[27]. Hardy-Weinberg Equilibrium (HWE) was tested
in controls using Plink v1.07 [37] at α = 0.05, and all
selected SNPs were in HWE.
Statistical analysis
The Chi-Square statistics was applied to test association
between 34 SNPs in ARNT2 and AS, using Plink v1.07.
We used Bonferroni correction to adjust P values at the
α threshold of significance (α = 0.05). Since Bonferroni
correction is conservative when the tests are not inde-
pendent, we used the SNPSpD web interface [38], to ac-
count for linkage disequilibrium (LD) patterns between
all SNPs in the current sample. The effective number of
independent loci was 21 and the subsequent threshold of
significance after Bonferroni correction was α = 0.0024. We
analysed LD blocks in our sample using Haploview [39].
Functional annotation of significant SNPs was con-
ducted using the following softwares: HaploReg v2 [40]
allows analysis of non-coding genetic variants in terms
of their effect on the organization of chromatin regions
and regulatory motifs; F-SNP [41] is a tool which com-
bines multiple databases for providing the functional
roles of genetic variants; the Genetic Association Data-
base [42] gives information about genetic studies which
previously identified association between the SNPs we
analysed and ASC; SNPnexus [43] is an online database
which was used to define regulatory elements and con-
served regions; the University of California Santa Cruz
(UCSC) genome browser [44] permits to validate func-
tions of the SNPs analysed.
Analysis of replication data
We had access to the summary data of the PGC data-
base and we checked for effect sizes and P values for
rs17225178 in the ASC cohort. The PGC analysed genome-
wide SNPs for association with ASC in 161 cases, 526
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all of Caucasian ancestry [29]. Details of methods, an-
cestry of the participants and analyses for this cohort
are provided in reference [29].
Consent and ethics
Participants gave their informed consent before partici-
pating in this study. The current study had ethics ap-
proval from the Cambridge Psychology Research Ethics
Committee and the NHS Research Ethics Committee
(UK) and was conducted in accordance with the princi-
ples of the Declaration of Helsinki.
Results
rs17225178 was significantly associated with AS in our
sample with P value = 0.001, and rs3848173 was nomin-
ally associated with AS in our sample. Minor alleles of
these two SNPs are more prevalent in cases than in con-
trols with odds ratio (OR) > 1 and are associated with an
increased risk of AS (Table 3). To replicate our associ-
ation, we searched for the P value and effect direction of
rs17225178 in the PGC dataset. rs17225178 was signifi-
cant (P value = 0.0121), and the effect direction was
same between the two datasets (OR > 1) (Table 3).
rs17225178 is included in a LD block (25 Kb) in our sam-
ple, alongside seven other SNPs (rs3848173, rs8036233,
rs3901896, rs17788120, rs3848175, rs895444 and rs12591546)
(Figure 1). rs17225178 is located in intron 2 of ARNT2,
alongside rs3848175 and rs895444. Intron 1 includes
rs8036233, rs3901896, rs3848173 and rs17788120; while
rs12591546 is located in intron 3 (Figure 2).
Discussion
The aim of this study was to investigate the role of com-
mon genetic variants in the predisposition to AS, which
is a high-functioning form of ASC. The complex genetic
nature of ASC has led previous studies to examine mul-
tiple genes, mainly involved in neural development and
connectivity, sex-hormones signaling and social-emotional
pathways [10,11,27]. In the current study, we tested for a
genetic association between 34 SNPs in ARNT2 with
AS, and then replicated our significant SNP in a large
ASC cohort. Our results show nominal association of
rs3848173 with AS and significant association betweenTable 3 Results of SNP association analyses in our sample an
SNP ID MAF (cases) MAF (controls) SNP association
our sample
OR X2
rs3848173 0.2288 0.1667 1.484 4.76
rs17225178 0.1966 0.1173 1.842 9.77
Nominally significant P values after genetic association analysis between 34 SNPs in
Bonferroni correction for total number of SNPs is written in bold and italicized (α =
genetic association analysis between rs17225178 and ASC in the PGC database are
minor allele frequency; OR, odds ratio; PGC, Psychiatric Genomics Consortium; SE, srs17225178 and AS. We replicated the association of
rs17225178 in the PGC ASC cohort, corroborating
previous reports that showed an involvement of ARNT2
in ASC. This is consistent with a previous study from
our laboratory which indicated nominal association of
rs3901896 with AS, and of rs4778599 with autistic
traits, measured using the AQ [27]. Recent studies have
reported a mutation in the ARNT2 gene in ASC [26] and
common variants associated with autistic traits [28].
ARNT2 is located on chromosome 15q24 and includes
20 exons and 19 introns (Figure 2). It spans 193.587 Kb
and has eight splice variants. Four transcript variants are
protein-coding: one is composed of the first 20 exons and
19 introns; two transcripts include the first 19 exons and 18
introns; one transcript includes the first 6 exons and 5
introns (UCSC genome browser). rs17225178 is located
in intron 2 (Figure 2) and modifies transcription factor
binding sites (TATA, GATA and TAL1 motifs) and
genomic regions that regulate the chromatin state in
neural cell lines (hippocampus and brain angular
gyrus) (HaploReg v2). SNP annotation did not indicate
the presence of miRNA binding sites or other struc-
tural variants at the level of this SNP and did not pro-
vide information about the effect of rs17225178 on
protein structure and function (F-SNP, SNPnexus). We
hypothesize that the presence of the risk allele of
rs17225178 could influence the binding of different
transcription factors or could allow the modification of
chromatin states, regulating chromatin accessibility
and dynamics. This genetic variant is included in a LD
block in our sample, where seven other SNPs (rs8036233,
rs3901896, rs3848173, rs17788120, rs3848175, rs895444
and rs12591546) that alter chromatin regulatory re-
gions in neural cell lines are located (HaploReg v2).
Two previous studies have reported nominal associ-
ation of rs3901896 with AS [27] and autistic traits (for ex-
ample, language impairment) [28]. This genetic variant is
in LD with rs17225178 in our sample (Figure 1). An inter-
esting next step will be to perform molecular studies to
analyse possible chromatin modifications and binding of
specific transcription factors at the level of regulatory re-
gions of ARNT2, carrying the risk allele or LD region.
This is the first study that shows a statistically signifi-
cant association of rs17225178 with AS and supportsd in the PGC database
analysis in SNP association analysis in the PGC
database
P value OR SE P value
8 0.029
3 0.001771 1.115 0.0433 0.0121
ARNT2 and AS in our sample are reported (α = 0.05). Significant P value after
0.0024). Major allele is the reference allele for the estimated OR. Results of
also reported. AS, Asperger Syndrome; ASC, Autism Spectrum Conditions; MAF,
tandard error for the odds ratio; SNP, single nucleotide polymorphism.
Figure 1 Linkage disequilibrium blocks in the ARNT2 gene calculated in our sample (detail). Block 3 is shown. It includes eight SNPs analysed
in the current study. Numbers into the squares indicate D’ values.
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in ASC. This is consistent with the role of ARNT2 in
neural development, as is known from animal models. In
particular, ARNT2 is involved in the development of oxy-
tocinergic neurons [15]. The oxytocinergic system has
been implicated in autism through multiple lines of evi-
dence [45-51]. This result provides further support for the
atypical oxytocinergic system in ASC by implicating a
gene involved in the development of oxytocinergic neu-
rons. In our study, we find a significant association withFigure 2 Schematic diagram of the ARNT2 gene. White boxes indicate
those in linkage disequilibrium with this genetic variant in our sample arers17225178, which is included in a LD block, alongside
rs3901896 that has been nominally associated with AS
[27] and autistic traits [28]. In the previous genetic study
carried out in our laboratory [27], we did not find associ-
ation between rs17225178 and AS, as we performed SNP
association analysis at the gene level and not for each SNP
independently.
The limitation of this study is the small sample size, so
further research is required to corroborate these results.
Animal models of Rett Syndrome have established a roleintrons. SNP significantly associated with AS in the current study and
indicated by blue lines.
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test if Arnt2 play an important role in underlying the
autistic phenotype. Future work in animals should em-
ploy well-designed behavioural assays relevant to autism
in Arnt2 knockout mice, such as social-preference para-
digms [52]. In humans, larger association studies of
ARNT2 SNPs with endophenotypes linked to autism will
be particularly relevant.
Conclusions
In the current study, we report a statistically significant
association between the genetic variant rs17225178 in
ARNT2 and AS. Using the PGC ASC dataset, we were
able to replicate our results in a larger cohort. The direc-
tion of effect was the same in both the cohorts. Our
findings provide evidence for the role of ARNT2 in ASC
and show the involvement of rs17225178 in this gene in
AS, a subgroup of ASC.
Abbreviations
AQ: Autism Spectrum Quotient; ARNT2: aryl-hydrocarbon receptor nuclear
translocator 2; AS: Asperger Syndrome; ASC: Autism Spectrum Conditions;
BAP: broader autism phenotype; BDNF: brain-derived neurotrophic factor;
bHLH-PAS: basic helix-loop-helix-Per-Arnt-Sim; CEU: Utah residents with
northern and western European ancestry; DSM-IV-TR: Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition, Text Revision;
GWAS: genome-wide association studies; HIF-1α: hypoxia-inducible factor-1α;
HWE: Hardy-Weinberg Equilibrium; ICD-10: International Statistical
Classification of Diseases and Related Health Problems, Tenth Revision;
LD: linkage disequilibrium; MAF: minor allele frequency; MECP2: methyl CpG
binding protein 2; NCBI: National Center for Biotechnology Information;
OR: odds ratio; PGC: Psychiatric Genomics Consortium; SIM1: single-minded
homolog 1; SNP: single nucleotide polymorphism; UCSC: University of
California Santa Cruz.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
BC and SBC designed the study. ADN analysed the data. VW and BC co-supervised
data analysis, and SBC received funding for the study. ADN, BC, SBC and VW wrote
the paper. All authors read and approved the final manuscript.
Authors’ information
ADN and VW are joint first authors; SBC and BC are joint senior authors.
Acknowledgments
We are grateful to Target Autism Genome, the Nancy Lurie Marks (NLM)
Family Foundation, the Autism Research Trust, the Medical Research Council
UK, the Max Planck Institute for Psycholinguistics and the Wellcome Trust
Sanger Centre. BC was funded by the Medical Research Council UK and VW
was funded by the Nehru Trust for Cambridge University and the Cambridge
Commonwealth Trust. We thank Robert Plomin, Frank Dudbridge, Lindsey
Kent and Ian Craig for relevant discussions, and Jon Breidbord, Allen Chan,
Sylvia Lakatosova, Sally Wheelwright, Carrie Allison, Uma Mallya, Alex Politt
and Leena Peltonen for support at different points of the project. The study
was carried out in collaboration with the NIHR CLAHRC EoE.
Author details
1Department of Psychiatry, Autism Research Centre, University of Cambridge,
Douglas House, 18B Trumpington Road, Cambridge CB2 8AH, UK.
2Cambridgeshire and Peterborough NHS Foundation Trust, CLASS Clinic,
Cambridge, UK. 3Centre for Integrative Neuroscience and Neurodynamics,
School of Psychology and Clinical Language Sciences, University of Reading,
Reading, UK.Received: 29 July 2014 Accepted: 12 February 2015
References
1. American Psychiatric Association: DSM-IV Diagnostic and Statistical Manual
of Mental Disorders, Text revision. 4th ed. Washington, DC: American
Psychiatric Association; 2000.
2. Baron-Cohen S, Scott FJ, Allison C, Williams JG, Bolton P, Matthews FE, et al.
Prevalence of autism-spectrum conditions: UK school-based population
study. Br J Psychiatry. 2009;194(6):500–9.
3. Gillberg C, Cederlund M, Lamberg K, Zeijlon L. Brief report: “the autism
epidemic”. The registered prevalence of autism in a Swedish urban area.
J Autism Dev Disord. 2006;36:429–35.
4. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool
children. JAMA-J Am Med Assoc. 2001;285:3093–9.
5. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B,
Knickmeyer R. Why are autism spectrum conditions more prevalent in
males? PLoS Biol. 2011;9(6):e1001081.
6. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al.
Genetic heritability and shared environmental factors among twin pairs
with autism. Arch Gen Psychiatry. 2011;68(11):1095–102.
7. Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a
decade of new twin studies. Am J Med Genet B Neuropsychiatr Genet.
2011;156B:255–74.
8. State MW, Levitt P. The conundrums of understanding genetic risks for
autism spectrum disorders. Nat Neurosci. 2011;14(12):1499–506.
9. Tordjman S, Somogyi E, Coulon N, Kermarrec S, Cohen D, Bronsard G, et al.
Gene x environment interactions in autism spectrum disorders: role of
epigenetic mechanisms. Frontiers in Psychiatry. 2014;5(53):1–17.
10. Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA,
Webb SJ. Autism and abnormal development of brain connectivity. J Neurosci.
2004;24(42):9228–31.
11. Abrahams BS, Geschwind DH. Advances in autism genetics: on the
threshold of a new neurobiology. Nat Rev Genet. 2008;9:341–55.
12. Hirose K, Morita M, Ema M, Mimura J, Hamada H, Fujii H, et al. cDNA
cloning and tissue-specific expression of a novel basic Helix-Loop-Helix/PAS
Factor (Arnt2) with close sequence similarity to the Aryl Hydrocarbon Receptor
Nuclear Translocator (Arnt). Mol Cell Biol. 1996;16(4):1706–13.
13. Webb EA, AlMutair A, Kelberman D, Bacchelli C, Chanudet E, Lescai F, et al.
ARNT2 mutation causes hypopituitarism, post-natal microcephaly, visual and
renal anomalies. Brain. 2013;136:3096–105.
14. Maltepe E, Keith B, Arsham AM, Brorson JR, Simon MC. The role of ARNT2 in
tumor angiogenesis and the neural response to hypoxia. Biochem Biophys
Res Commun. 2000;273:231–8.
15. Michaud JL, DeRossi C, May NR, Holdener BC, Fan CM. ARNT2 acts as the
dimerization partner of SIM1 for the development of the hypothalamus.
Mech Dev. 2000;90(2):253–61.
16. Ramachandrappa S, Raimondo A, Cali AMG, Keogh JM, Henning E, Saeed S,
et al. Rare variants in single-minded 1 (SIM1) are associated with severe
obesity. J Clin Invest. 2013;123(7):3042–50.
17. Zoghbi HY. MeCP2 dysfunction in humans and mice. J Child Neurol.
2005;20(9):736–40.
18. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. A mouse Mecp2-null mutation
causes neurological symptoms that mimic Rett syndrome. Nat Genet.
2001;27:322–6.
19. Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J,
et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features
and display hyperacetylation of histone H3. Neuron. 2002;35(2):243–54.
20. Fyffe SL, Neul JL, Samaco RC, Chao HT, Ben-Shachar S, Moretti P, et al.
Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for
MeCP2 in feeding behavior, aggression, and the response to stress.
Neuron. 2008;59(6):947–58.
21. Hosoya T, Oda Y, Takahashi S, Morita M, Kawauchi S, Ema M, et al. Defective
development of secretory neurones in the hypothalamus of Arnt2-knockout
mice. Genes Cells. 2001;6:361–74.
22. Schweitzer J, LöhR H, Bonkowsky JL, Hübscher K, Driever W. Sim1a and Arnt2
contribute to hypothalamo-spinal axon guidance by regulating Robo2 activity
via a Robo3- dependent mechanism. Development. 2013;140(1):93–106.
23. Valen E, Pascarella G, Chalk A, Maeda N, Kojima M, Kawazu C, et al.
Genome-wide detection and analysis of hippocampus core promoters using
DeepCAGE. Genome Res. 2009;19(2):255–65.
Di Napoli et al. Molecular Autism  (2015) 6:9 Page 7 of 724. Pruunsild P, Sepp M, Orav E, Koppel I, Timmusk T. Identification of cis-elements
and transcription factors regulating neuronal activity-dependent transcription
of human BDNF gene. J Neurosci. 2011;31(9):3295–308.
25. Lin M, Zhao D, Hrabovsky A, Pedrosa E, Zheng D, Lachman HM. Heat shock
alters the expression of schizophrenia and autism candidate genes in an
induced pluripotent stem cell model of the human telencephalon. PLoS
One. 2014;9(4):e94968.
26. Vaags AK, Lionel AC, Sato D, Goodenberger M, Stein QP, Curran S, et al.
Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J
Hum Genet. 2012;90(1):133–41.
27. Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C,
et al. Genes related to sex steroids, neural growth, and social-emotional
behavior are associated with autistic traits, empathy, and Asperger Syndrome.
Autism Res. 2009;2:157–77.
28. Hovey D, Zettergren A, Jonsson L, Melke J, Anckarsäter H, Lichtenstein P,
et al. Associations between oxytocin-related genes and autistic-like traits.
Soc Neurosci. 2014;9(4):378–86.
29. Cross-disorder group of the Psychiatric Genomics Consortium. Identification
of risk loci with shared effects on five major psychiatric disorders: a
genome-wide analysis. Lancet. 2013;381(9875):1371–9. http://www.med.unc.
edu/pgc/downloads.
30. Robinson E, Munir K, Munafò MR, Hughes M, McCormick M, Koenen KC. Stability
of autistic traits in the general population: further evidence for a continuum of
impairment. J Am Acad Child Adolesc Psychiatry. 2011;50(4):376–84.
31. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The Autism-Spectrum
Quotient (AQ): evidence from Asperger Syndrome/high-functioning autism, males
and females, scientists and mathematicians. J Autism Dev Disord. 2001;31(1):5–17.
32. World Health Organization. The ICD-10 classification of mental and behavioural
disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health
Organization; 1992.
33. Wheelwright S, Auyeung B, Allison C, Baron-Cohen S. Defining the broader,
medium and narrow autism phenotype among parents using the Autism
Spectrum Quotient (AQ). Molecular Autism. 2010;1:10.
34. Hoekstra RA, Bartels M, Verweij CJH, Boomsma DI. Heritability of autistic
traits in the general population. Arch Pediatr Adolesc Med. 2007;161:372–7.
35. Collins FS, Guyer MS, Chakravarti A. Variations on a theme: cataloging
human DNA sequence variation. Science. 1997;278(5343):1580–1.
36. Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW. DNA from buccal
swabs recruited by mail: evaluation of storage effects on long-term stability
and suitability for multiplex polymerase chain reaction genotyping. Behav
Genet. 2003;33(1):67–72.
37. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. A
tool set for whole-genome association and population-based linkage analyses.
Am J Hum Genet. 2007;81:559–75. http://pngu.mgh.harvard.edu/~purcell/plink/.
38. Nyholt DR. A simple correction for multiple testing for SNPs in linkage
disequilibrium with each other. Am J Hum Genet. 2004;74(4):765–9.
http://gump.qimr.edu.au/general/daleN/SNPSpD/.
39. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of
LD and haplotype maps. Bioinformatics. 2005;21(2):263–5.
40. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states,
conservation, and regulatory motif alterations within sets of genetically linked
variants. Nucleic Acids Res. 2012;40(D1):D930–4. http://www.broadinstitute.org/
mammals/haploreg/haploreg.php.
41. Lee PH, Shatkay H. An integrative scoring system for ranking SNPs by their
potential deleterious effects. Bioinformatics. 2009;25(8):1048–55. http://compbio.
cs.queensu.ca/F-SNP/.
42. Becker KG, Barnes KC, Bright TJ, Wang SA. The genetic association database.
Nat Genet. 2004;36(5):431–2. http://geneticassociationdb.nih.gov/.
43. Chelala C, Khan A, Lemoine NR. SNPnexus: A web database for functional
annotation of newly discovered and public domain single nucleotide
polymorphisms. Bioinformatics. 2009;25(5):655–61. http://snp-nexus.org/.
44. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al.
The human genome browser at UCSC. Genome Res. 2002;12(6):996–1006.
http://genome.ucsc.edu/.
45. Green JJ, Hollander E. Autism and oxytocin: new developments in
translational approaches to therapeutics. Neurotherapeutics. 2010;7(3):250–7.
46. Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, et al.
Intranasal oxytocin improves emotion recognition for youth with autism
spectrum disorders. Biol Psychiatry. 2010;67(7):692–4.47. Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR,
et al. Oxytocin infusion reduces repetitive behaviors in adults with autistic
and Asperger’s disorders. Neuropsychopharmacology. 2003;28:193–8.
48. Insel TR, O’Brien DJ, Leckman JF. Oxytocin, vasopressin and autism: is there
a connection? Biol Psychiatry. 1999;45:145–57.
49. Modahl C, Green L, Fein D, Morris M, Waterhouse L, Feinstein C, et al.
Plasma oxytocin levels in autistic children. Biol Psychiatry. 1998;43(4):270–7.
50. Wu S, Jia M, Ruan Y, Liu J, Guo Y, Shuang M, et al. Positive association of
the oxytocin receptor gene (OXTR) with autism in the Chinese Han Population.
Biol Psychiatry. 2005;58:74–7.
51. Yrigollen C, Han SS, Kochetkova A, Babitz T, Chang JT, Volkmar FR, et al.
Genes controlling affiliative behavior as candidate genes for autism.
Biol Psychiatry. 2008;63:911–6.
52. Silverman JL, Yang M, Turner SM, Katz AM, Bell DB, Koenig JI, et al. Low stress
reactivity and neuroendocrine factors in the BTBR T + tf/J mouse model of
autism. Neuroscience. 2010;171(4):1197–208.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
